A citation-based method for searching scientific literature

Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
Times Cited: 307







List of co-cited articles
533 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
172
27

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
369
26

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
432
25

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
181
22

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
364
21

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
308
20

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
79
25

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
104
19

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
197
16


A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
306
15


Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017
75
17

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
132
13

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
147
13

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
105
13

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
216
13

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
206
12

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
166
12

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
198
12

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
188
12

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
202
11

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
47
21

Rethinking the Standard for Ductal Carcinoma In Situ Treatment.
Laura Esserman, Christina Yau. JAMA Oncol 2015
65
15

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Lotte E Elshof, Marjanka K Schmidt, Emiel J Th Rutgers, Flora E van Leeuwen, Jelle Wesseling, Michael Schaapveld. Ann Surg 2018
30
33


Cancer statistics: Breast cancer in situ.
Elizabeth M Ward, Carol E DeSantis, Chun Chieh Lin, Joan L Kramer, Ahmedin Jemal, Betsy Kohler, Otis W Brawley, Ted Gansler. CA Cancer J Clin 2015
135
10

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
B Fisher, J Dignam, N Wolmark, D L Wickerham, E R Fisher, E Mamounas, R Smith, M Begovic, N V Dimitrov, R G Margolese,[...]. Lancet 1999
700
9

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Yasuaki Sagara, Rachel A Freedman, Ines Vaz-Luis, Melissa Anne Mallory, Stephanie M Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. J Clin Oncol 2016
80
11

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
Nina Bijker, Philip Meijnen, Johannes L Peterse, Jan Bogaerts, Irène Van Hoorebeeck, Jean-Pierre Julien, Massimiliano Gennaro, Philippe Rouanet, Antoine Avril, Ian S Fentiman,[...]. J Clin Oncol 2006
430
9

Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.
Kirsty E Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen, John Boyages. BMC Cancer 2015
45
20

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
101
9

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk.
Troy Bremer, Pat W Whitworth, Rakesh Patel, Jess Savala, Todd Barry, Stephen Lyle, Glen Leesman, Steven P Linke, Karin Jirström, Wenjing Zhou,[...]. Clin Cancer Res 2018
36
25

Detection of ductal carcinoma in situ in women undergoing screening mammography.
Virginia L Ernster, Rachel Ballard-Barbash, William E Barlow, Yingye Zheng, Donald L Weaver, Gary Cutter, Bonnie C Yankaskas, Robert Rosenberg, Patricia A Carney, Karla Kerlikowske,[...]. J Natl Cancer Inst 2002
421
8

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
96
8



Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
39
20

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
89
8

Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Rinku Sutradhar, Frederick L Baehner, Dave P Miller, Cindy Fong, Sumei Gu, Alan Tuck, Sandip Sengupta,[...]. J Natl Cancer Inst 2017
39
20

Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
63
11

Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
John R Benson, Ismail Jatoi, Masakazu Toi. Lancet Oncol 2016
43
16



Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
Marc D Ryser, Mathias Worni, Elizabeth L Turner, Jeffrey R Marks, Rick Durrett, E Shelley Hwang. J Natl Cancer Inst 2015
36
19

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
John F Forbes, Ivana Sestak, Anthony Howell, Bernardo Bonanni, Nigel Bundred, Christelle Levy, Gunter von Minckwitz, Wolfgang Eiermann, Patrick Neven, Michael Stierer,[...]. Lancet 2016
86
8

The diagnostic challenge of low-grade ductal carcinoma in situ.
Tracy Onega, Donald L Weaver, Paul D Frederick, Kimberly H Allison, Anna N A Tosteson, Patricia A Carney, Berta M Geller, Gary M Longton, Heidi D Nelson, Natalia V Oster,[...]. Eur J Cancer 2017
22
31

Controversies in the Treatment of Ductal Carcinoma in Situ.
Andrea V Barrio, Kimberly J Van Zee. Annu Rev Med 2017
33
21

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
Andrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Cristiana Taverniti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano,[...]. J Clin Oncol 2019
57
12

Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
Marc D Ryser, Donald L Weaver, Fengmin Zhao, Mathias Worni, Lars J Grimm, Roman Gulati, Ruth Etzioni, Terry Hyslop, Sandra J Lee, E Shelley Hwang. J Natl Cancer Inst 2019
23
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.